Chapter 7 Clinical Relevance of BNP Measurement in the Follow‐Up of Patients with Chronic Heart Failure
Authors:
- Aldo ClericoACAldo Clerico
- Marianna FontanaMFMarianna Fontana
- Andrea RipoliARAndrea Ripoli
- Michele EmdinMEMichele Emdin
- 1 January 2009
- book chapter
- Published by Elsevier
- Vol. 48, 163-179
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspneaEuropean Journal of Internal Medicine, 2009
- Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)JACC, 2008
- Cross-Reactivity of BNP, NT-proBNP, and proBNP in Commercial BNP and NT-proBNP Assays: Preliminary Observations from the IFCC Committee for Standardization of Markers of Cardiac DamageClinical Chemistry, 2008
- Meta‐analysis of B type natriuretic peptide and N‐terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunctionInternal Medicine Journal, 2007
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biomarkers of Heart FailureCirculation, 2007
- Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or BothThe American Journal of Cardiology, 2005
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the AdultJACC, 2005
- Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A ReviewClinical Chemistry, 2004
- Effect of Beta-Blocker on Left Ventricular Function and Natrituretic Peptides in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme InhibitorJapanese Circulation Journal, 2000
- Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.Heart, 1996